Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Orgenesis Inc. (ORGS) vs Heatwurx Inc. (PCSA)

Orgenesis Inc. and Heatwurx Inc. are both Biotechnology companies. Orgenesis Inc. and Heatwurx Inc. are of similar size ($5.7M and $5.2M). Orgenesis Inc. has negative trailing earnings, so its P/E is not meaningful; Heatwurx Inc. trades at 1.8×. Orgenesis Inc. grew revenue faster over the last twelve months: 95.3% against −34.5%. Heatwurx Inc. has the higher net margin (0.00% vs −4,653.6%) and the higher return on invested capital (0.00% vs 0.00%). Across the 15 metrics below, Heatwurx Inc. leads on 9 and Orgenesis Inc. on 6.

Valuation

Metric ORGS PCSA Biotechnology median
P/E n/m 1.75 7.88
P/S 2.03 38.64 11.47
P/B n/m n/m 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales 17.50 38.45 10.73
Earnings yield (2,302.00%) 57.14% (28.84%)
Free cash flow yield (823.55%) (259.68%) (23.03%)

Profitability

Metric ORGS PCSA Biotechnology median
Gross margin (86.28%) 0.00% 65.16%
Operating margin (3,842.32%) 0.00% 0.00%
Net margin (4,653.62%) 0.00% 0.00%
Free cash flow margin (1,675.27%) 0.00% 0.00%
Return on equity 164.62% (464.19%) (57.72%)
Return on assets (605.73%) (262.17%) (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ORGS PCSA Biotechnology median
Revenue growth (TTM) 95.28% (34.50%) 5.64%
EPS growth (last fiscal year) 40.10% 89.29% —
Revenue growth, 5-year CAGR (23.30%) — 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ORGS PCSA Biotechnology median
Debt to equity (0.44) 0.00 0.00
Current ratio 0.03 0.87 4.73
Net debt to EBITDA (0.42) 0.40 0.96

Dividend

Metric ORGS PCSA Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric ORGS PCSA Biotechnology median
Market cap 5.68m 5.17m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack